2023 Key Dates
|2024 Membership Applications Open||13-August-2023|
|2024 Award Nominations||21-August-2023|
|2024 Membership Application Deadline||29-September-2023|
|47th Annual Meeting - Registration Opens||11-September-2023|
|Abstract Submissions for 47th Annual Meeting Opens||11-September-2023|
|Research Grant Applications Open||02-October-2023|
About the Macula Society
Founded in 1977, the Macula Society is a forum for new research in retinal vascular and macular diseases. Membership is by application, with acceptance criteria including extensive contribution to retinal literature. The Macula Society recognizes outstanding achievement by its members and others through awards and lectures, and holds an annual meeting open to members, their guests, co-authors, and supporting company representatives.
Our email address has changed! Please use
for all future communications!
Judy E. Kim, MD
Mark W. Johnson, MD
Immediate Past President
Glenn J. Jaffee, MD
Macula Society Endowment Fund
The Macula Society Educational Endowment provides a revenue stream to fund various educational initiatives in perpetuity, independent of year-to-year fluctuations in corporate support and other society income sources.
Join us for the 6th Biennial Symposium on AMD, taking place on September 29-30, 2023, at the Starr Center at the Schepens Eye Research Institute of Mass Eye and Ear in Boston. The conference aims to highlight the latest innovations in AMD disease research. This event promises in-depth and thoughtful discussions on the pathogenesis of AMD, with national and international experts in various fields, including Omics, Immunity, Oxidative Stress, Aging, Retinal Pigment Epithelium, and In Vitro Models. With 200-250 anticipated attendees, including clinician-scientists, researchers, industry representatives, and trainees, this symposium is the perfect platform for networking and exchanging ideas. The sessions will be moderated by experts in the field and will feature short talks followed by an extended panel discussion. Register now to join this informative and engaging symposium!
Registration Link: https://www.eventleaf.com/e/2023AMD
September 7-9, 2023
Santa Clara, California
Join the Interest List at:
The DRCR Retina Network is planning an exciting new Phase III clinical trial to prevent visual acuity loss due to radiation retinopathy (RR). Eligible participants will be randomized to receive either repeated injections of anti-VEGF, long-active steroid, or observation following treatment of choroidal melanoma with I-125 plaque brachytherapy.
Any interested physicians or clinical sites should contact email@example.com to learn more about joining the Network.